Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (31-40 of 361) with videos related to

Pageof 37
Sort By:
The Lancet. Oncology|February 7, 2020
Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?Sabine Schmid, Martin Früh, Solange Peters
Cell|January 28, 2021
Strength in numbers: predicting response to checkpoint inhibitors from large clinical datasetsAlbrecht Stenzinger, Daniel Kazdal, Solange Peters
Translational Lung Cancer Research|May 17, 2023
Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectivesMark G Kris, Tetsuya Mitsudomi, Solange Peters
Revue Medicale Suisse|May 19, 2021
Pierre-Yves Dietrich, Matti Aapro, Solange Peters
Revue Medicale Suisse|May 16, 2019
Matti Aapro, Solange Peters, Pierre-Yves Dietrich
Cancer Discovery|April 3, 2021
Treatment Decisions for Patients with Cancer during the COVID-19 PandemicChris Labaki, Solange Peters, Toni K Choueiri
Revue Medicale Suisse|June 22, 2017
Matti Aapro, Pierre-Yves Dietrich, Solange Peters
Cancer Treatment Reviews|April 16, 2026
Integrin beta-6: Its emerging role as a therapeutic target in solid tumorsRachel E Sanborn, Solange Peters, David Barbie
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2025
Adjuvant Immunotherapy Should Be Used in Patients With Non-Small Cell Carcinoma With a Pathologic Complete Response to Neoadjuvant ImmunotherapyDipesh Uprety, Anja C Roden, Solange Peters
Revue Medicale Suisse|May 29, 2020
Pierre-Yves Dietrich, Matti Aapro, Solange Peters
Pageof 37

Showing results (31-40 of 361) with videos related to

Sort By:
Pageof 37
The Lancet. Oncology|February 7, 2020
Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?Sabine Schmid, Martin Früh, Solange Peters
Cell|January 28, 2021
Strength in numbers: predicting response to checkpoint inhibitors from large clinical datasetsAlbrecht Stenzinger, Daniel Kazdal, Solange Peters
Translational Lung Cancer Research|May 17, 2023
Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectivesMark G Kris, Tetsuya Mitsudomi, Solange Peters
Revue Medicale Suisse|May 19, 2021
Pierre-Yves Dietrich, Matti Aapro, Solange Peters
Revue Medicale Suisse|May 16, 2019
Matti Aapro, Solange Peters, Pierre-Yves Dietrich
Cancer Discovery|April 3, 2021
Treatment Decisions for Patients with Cancer during the COVID-19 PandemicChris Labaki, Solange Peters, Toni K Choueiri
Revue Medicale Suisse|June 22, 2017
Matti Aapro, Pierre-Yves Dietrich, Solange Peters
Cancer Treatment Reviews|April 16, 2026
Integrin beta-6: Its emerging role as a therapeutic target in solid tumorsRachel E Sanborn, Solange Peters, David Barbie
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2025
Adjuvant Immunotherapy Should Be Used in Patients With Non-Small Cell Carcinoma With a Pathologic Complete Response to Neoadjuvant ImmunotherapyDipesh Uprety, Anja C Roden, Solange Peters
Revue Medicale Suisse|May 29, 2020
Pierre-Yves Dietrich, Matti Aapro, Solange Peters
Pageof 37